These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36356792)

  • 1. Combination of BauA and OmpA elicit immunoprotection against Acinetobacter baumannii in a murine sepsis model.
    Tamehri M; Rasooli I; Pishgahi M; Jahangiri A; Ramezanalizadeh F; Banisaeed Langroodi SR
    Microb Pathog; 2022 Dec; 173(Pt A):105874. PubMed ID: 36356792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BauA and Omp34 surface loops trigger protective antibodies against Acinetobacter baumannii in a murine sepsis model.
    Akbari Z; Rasooli I; Ghaini MH; Chaudhuri S; Farshchi Andisi V; Jahangiri A; Ramezanalizadeh F; Schryvers AB
    Int Immunopharmacol; 2022 Jul; 108():108731. PubMed ID: 35367743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-protein cocktail elicits a protective immune response against Acinetobacter baumannii in a murine infection model.
    Mirali M; Jahangiri A; Jalali Nadoushan M; Rasooli I
    Microb Pathog; 2023 Sep; 182():106262. PubMed ID: 37474079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced immunoprotection against Acinetobacter baumannii infection: Synergistic effects of Bap and BauA in a murine model.
    Mansouri M; Sadeghpoor M; Jahangiri A; Ghaini MH; Rasooli I
    Immunol Lett; 2023 Oct; 262():18-26. PubMed ID: 37652189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid antigens expressing surface loops of BauA from
    Chaudhuri S; Rasooli I; Oskouei RH; Pishgahi M; Jahangir A; Andisi VF; Schryvers AB
    Front Immunol; 2022; 13():933445. PubMed ID: 36045685
    [No Abstract]   [Full Text] [Related]  

  • 6. Protective response against
    Ramezanalizadeh F; Rasooli I; Owlia P
    Future Microbiol; 2021 Feb; 16(3):143-157. PubMed ID: 33528272
    [No Abstract]   [Full Text] [Related]  

  • 7. Exploitation of two siderophore receptors, BauA and BfnH, for protection against Acinetobacter baumannii infection.
    Aghajani Z; Rasooli I; Mousavi Gargari SL
    APMIS; 2019 Dec; 127(12):753-763. PubMed ID: 31512768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii.
    Zhang X; Yang T; Cao J; Sun J; Dai W; Zhang L
    Microb Pathog; 2016 Jul; 96():20-5. PubMed ID: 27133268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo validation of the immunogenicity of recombinant Baumannii Acinetobactin Utilization A protein (rBauA).
    Esmaeilkhani H; Rasooli I; Nazarian S; Sefid F
    Microb Pathog; 2016 Sep; 98():77-81. PubMed ID: 27374893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
    Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
    Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Omp34 antibodies protect against Acinetobacter baumannii in a murine sepsis model.
    Naghipour Erami A; Rasooli I; Jahangiri A; Darvish Alipour Astaneh S
    Microb Pathog; 2021 Dec; 161(Pt B):105291. PubMed ID: 34798280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of nosocomial Acinetobacter baumannii infections with a conserved immunogenic fimbrial protein.
    Mahmoudi Z; Rasooli I; Jahangiri A; Darvish Alipour Astaneh S
    APMIS; 2020 Jul; 128(7):476-483. PubMed ID: 32445596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic immunoprotection by Oma87 and Bap against Acinetobacter baumannii sepsis model.
    Mansouri M; Sadeghpoor M; Abdollahi M; Vafaei AJ; Jalali Nadoushan M; Rasooli I
    Int Immunopharmacol; 2023 Sep; 122():110650. PubMed ID: 37454632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
    Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B
    PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of novel monoclonal antibodies against outer membrane protein A (OmpA) of Acinetobacter baumannii.
    Yeganeh O; Shabani M; Pakzad P; Mosaffa N; Hashemi A
    J Immunol Methods; 2021 Dec; 499():113169. PubMed ID: 34666009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico design of a novel hybrid epitope-based antigen harboring highly exposed immunogenic peptides of BamA, OmpA, and Omp34 against Acinetobacter baumannii.
    Hessami A; Mogharari Z; Rahim F; Khalesi B; Jamal Nassrullah O; Reza Rahbar M; Khalili S; Jahangiri A
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113066. PubMed ID: 39241518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation the reactivity of a peptide-based monoclonal antibody derived from OmpA with drug resistant pulsotypes of Acinetobacter baumannii as a potential therapeutic approach.
    Yeganeh O; Shabani M; Pakzad P; Mosaffa N; Hashemi A
    Ann Clin Microbiol Antimicrob; 2022 Jun; 21(1):30. PubMed ID: 35773688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccine encoding OmpA and Pal from Acinetobacter baumannii efficiently protects mice against pulmonary infection.
    Lei L; Yang F; Zou J; Jing H; Zhang J; Xu W; Zou Q; Zhang J; Wang X
    Mol Biol Rep; 2019 Oct; 46(5):5397-5408. PubMed ID: 31342294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of conserved cork and β-barrel domains of baumannii acinetobactin utilization protein in an animal model.
    Sangroodi YH; Rasooli I; Nazarian S; Ebrahimizadeh W; Sefid F
    Turk J Med Sci; 2015; 45(6):1396-402. PubMed ID: 26775400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity and immunotherapeutic potential of BamA recombinant protein from Acinetobacter baumannii.
    Vieira de Araujo AE; Conde LV; da Silva Junior HC; de Almeida Machado L; Lara FA; Chapeaurouge A; Pauer H; Pires Hardoim CC; Martha Antunes LC; D'Alincourt Carvalho-Assef AP; Moreno Senna JP
    Microbes Infect; 2021; 23(4-5):104801. PubMed ID: 33582283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.